Press
releases

EXSCALATE4COV: Italian Medicines Agency (AIFA) authorizes Raloxifene Clinical Trial for Paucisymptomatic Covid-19 Patients treated at Home and in Medical Facilities

October 27, 2020

Dompé Appoints New Global Biotech Head

September 21, 2020

EU-supported Private-Public Consortium Exscalate4CoV : Raloxifene proposed for clinical trials after tests show it inhibits SARS-CoV-2

June 18, 2020

Dompé Presents Phase II Clinical Trial Results for Ladarixin in New-Onset Type 1 Diabetes at the American Diabetes Association’s Scientific Sessions

June 15, 2020

Dompé to Present Phase II Clinical Data for Ladarixin in New-Onset Type 1 Diabetes (T1D) at the American Diabetes Association’s Scientific Sessions

June 8, 2020

AIFA Announces Italian Authorization of Phase 2/3 Clinical Trial of Dompé’s Reparixin for the Treatment of Severe Patients with COVID-19 Pneumonia

May 12, 2020

Exscalate4CoV supercomputing platform wins 3 million euro EU funding to hunt for new drugs against Coronavirus pandemic

March 6, 2020

Exscalate4CoV: EU’s supercomputing and life science champions gear-up to fight Coronavirus pandemic

February 17, 2020

The Galien Foundation Debuts 2019 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Medical Technology" Categories

July 15, 2019

EXSCALATE, EPIDEMICS: Exscalate is the world's most powerful supercomputing platform

April 9, 2019